Skip to main content
Top
Published in: Cancer Causes & Control 1/2015

01-01-2015 | Brief report

International testicular cancer incidence trends: generational transitions in 38 countries 1900–1990

Authors: Ariana Znaor, Joannie Lortet-Tieulent, Mathieu Laversanne, Ahmedin Jemal, Freddie Bray

Published in: Cancer Causes & Control | Issue 1/2015

Login to get access

Abstract

Purpose

Rapid increases in testicular cancer incidence have marked the second half of the last century. While these secular rises, observed mainly in countries attaining the highest levels of human development, appear to have attenuated in the last decade, rates continue to increase in countries transiting toward high developmental levels. The purpose of our study was to provide a comprehensive analysis and presentation of the cohort-specific trends in testicular cancer incidence rates in 38 countries worldwide.

Methods

We used an augmented version of the Cancer Incidence in Five Continents series to analyze testicular cancer incidence in men aged 15–54 in 38 countries, via age–period–cohort analysis.

Results

In many European countries, the USA, Canada, Australia, and New Zealand, there is a continuation of the increasing risk among successive generations, yet rates are attenuating in male cohorts born since the 1970s in several Northern European countries, in contrast to the steeply increasing trends in recent cohorts in Southern Europe. Incidence rates have also been increasing in the populations traditionally at rather low risk, such as in the Philippines, Singapore, China, and Costa Rica.

Conclusions

The attenuation of testicular cancer risk in younger generations (in the most developed countries) alongside concomitant increases (in countries undergoing developmental change) is indicative of a global transition in the risk of testicular cancer. While identifying the underlying causes remains a major challenge, increasing awareness and adapting national healthcare systems to accommodate a growing burden of testicular cancer may prevent future avoidable deaths in young men.
Literature
1.
go back to reference Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099–3111PubMedCrossRef Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099–3111PubMedCrossRef
2.
go back to reference Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19(5):1151–1159PubMedCentralPubMedCrossRef Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19(5):1151–1159PubMedCentralPubMedCrossRef
3.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France. http://globocan.iarc.fr Ferlay J, Soerjomataram I, Ervik M, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France. http://​globocan.​iarc.​fr
4.
go back to reference Bergstrom R, Adami HO, Mohner M et al (1996) Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88(11):727–733PubMedCrossRef Bergstrom R, Adami HO, Mohner M et al (1996) Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88(11):727–733PubMedCrossRef
5.
go back to reference Bray F, Richiardi L, Ekbom A et al (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15(4):652–658PubMedCrossRef Bray F, Richiardi L, Ekbom A et al (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15(4):652–658PubMedCrossRef
6.
go back to reference Richiardi L, Bellocco R, Adami HO et al (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13(12):2157–2166PubMed Richiardi L, Bellocco R, Adami HO et al (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13(12):2157–2166PubMed
7.
go back to reference Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW (2008) Testicular cancer: marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer 122(3):639–642PubMedCrossRef Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW (2008) Testicular cancer: marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer 122(3):639–642PubMedCrossRef
8.
go back to reference Kanetsky PA, Mitra N, Vardhanabhuti S et al (2009) Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet 41(7):811–815PubMedCentralPubMedCrossRef Kanetsky PA, Mitra N, Vardhanabhuti S et al (2009) Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet 41(7):811–815PubMedCentralPubMedCrossRef
9.
go back to reference Chung CC, Kanetsky PA, Wang Z et al (2013) Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet 45(6):680–685PubMedCrossRef Chung CC, Kanetsky PA, Wang Z et al (2013) Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet 45(6):680–685PubMedCrossRef
10.
go back to reference Ruark E, Seal S, McDonald H et al (2013) Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet 45(6):686–689PubMedCrossRef Ruark E, Seal S, McDonald H et al (2013) Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet 45(6):686–689PubMedCrossRef
11.
go back to reference McGlynn KA (2001) Environmental and host factors in testicular germ cell tumors. Cancer Invest 19(8):842–853PubMedCrossRef McGlynn KA (2001) Environmental and host factors in testicular germ cell tumors. Cancer Invest 19(8):842–853PubMedCrossRef
12.
go back to reference Garner MJ, Turner MC, Ghadirian P, Krewski D (2005) Epidemiology of testicular cancer: an overview. Int J Cancer 116(3):331–339PubMedCrossRef Garner MJ, Turner MC, Ghadirian P, Krewski D (2005) Epidemiology of testicular cancer: an overview. Int J Cancer 116(3):331–339PubMedCrossRef
13.
go back to reference Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2009) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the mother. Int J Epidemiol 38(6):1532–1542PubMedCentralPubMedCrossRef Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2009) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the mother. Int J Epidemiol 38(6):1532–1542PubMedCentralPubMedCrossRef
14.
go back to reference Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2010) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the son. Int J Epidemiol 39(6):1605–1618PubMedCentralPubMedCrossRef Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2010) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the son. Int J Epidemiol 39(6):1605–1618PubMedCentralPubMedCrossRef
15.
go back to reference Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F (2011) Trends in mortality from urologic cancers in Europe, 1970–2008. Eur Urol 60(1):1–15PubMedCrossRef Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F (2011) Trends in mortality from urologic cancers in Europe, 1970–2008. Eur Urol 60(1):1–15PubMedCrossRef
16.
go back to reference Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E (2001) Western and eastern European trends in testicular cancer mortality. Lancet 357(9271):1853–1854PubMedCrossRef Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E (2001) Western and eastern European trends in testicular cancer mortality. Lancet 357(9271):1853–1854PubMedCrossRef
18.
go back to reference Znaor A, Bray F (2012) Thirty year trends in testicular cancer mortality in Europe: gaps persist between the East and West. Acta Oncol 51(7):956–958PubMedCrossRef Znaor A, Bray F (2012) Thirty year trends in testicular cancer mortality in Europe: gaps persist between the East and West. Acta Oncol 51(7):956–958PubMedCrossRef
19.
go back to reference Bertuccio P, Malvezzi M, Chatenoud L et al (2007) Testicular cancer mortality in the Americas, 1980–2003. Cancer 109(4):776–779PubMedCrossRef Bertuccio P, Malvezzi M, Chatenoud L et al (2007) Testicular cancer mortality in the Americas, 1980–2003. Cancer 109(4):776–779PubMedCrossRef
20.
go back to reference McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70PubMedCrossRef McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70PubMedCrossRef
21.
go back to reference Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR, Forman D (2010) Cancer incidence in five continents, volumes I to IX: IARC CancerBase No. 9. International Agency for Research on Cancer, Lyon, France. http://ci5.iarc.fr Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR, Forman D (2010) Cancer incidence in five continents, volumes I to IX: IARC CancerBase No. 9. International Agency for Research on Cancer, Lyon, France. http://​ci5.​iarc.​fr
22.
go back to reference Doll R, Payne P, Waterhouse J (1966) Cancer incidence in five continents, vol I. Union Internationale Contre le Cancer, Geneva, Switzerland Doll R, Payne P, Waterhouse J (1966) Cancer incidence in five continents, vol I. Union Internationale Contre le Cancer, Geneva, Switzerland
23.
go back to reference Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 6(4):449–467PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 6(4):449–467PubMedCrossRef
24.
go back to reference Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: age–period–cohort models. Stat Med 6(4):469–481PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: age–period–cohort models. Stat Med 6(4):469–481PubMedCrossRef
25.
go back to reference Rutherford M, Lambert P, Thompson J (2010) Age-Period-cohort modelling. Stata J 10(4):606–627 Rutherford M, Lambert P, Thompson J (2010) Age-Period-cohort modelling. Stata J 10(4):606–627
26.
go back to reference StataCorp LP (2011) Stata statistical software. College Station, TX StataCorp LP (2011) Stata statistical software. College Station, TX
27.
go back to reference Skakkebaek NE, Rajpert-De ME, Jorgensen N et al (2007) Testicular cancer trends as ‘whistle blowers’ of testicular developmental problems in populations. Int J Androl 30(4):198–204PubMedCrossRef Skakkebaek NE, Rajpert-De ME, Jorgensen N et al (2007) Testicular cancer trends as ‘whistle blowers’ of testicular developmental problems in populations. Int J Androl 30(4):198–204PubMedCrossRef
28.
go back to reference Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J (1987) Carcinoma-in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10(1):19–28PubMedCrossRef Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J (1987) Carcinoma-in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10(1):19–28PubMedCrossRef
29.
go back to reference Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81(21):1668–1669PubMedCrossRef Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81(21):1668–1669PubMedCrossRef
30.
go back to reference Moller H (1993) Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 23(1):8–13PubMed Moller H (1993) Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 23(1):8–13PubMed
31.
go back to reference Le Cornet C, Lortet-Tieulent J, Forman D et al (2013) Testicular cancer incidence to rise by 25 % by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer 50(4):831–839PubMedCrossRef Le Cornet C, Lortet-Tieulent J, Forman D et al (2013) Testicular cancer incidence to rise by 25 % by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer 50(4):831–839PubMedCrossRef
Metadata
Title
International testicular cancer incidence trends: generational transitions in 38 countries 1900–1990
Authors
Ariana Znaor
Joannie Lortet-Tieulent
Mathieu Laversanne
Ahmedin Jemal
Freddie Bray
Publication date
01-01-2015
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 1/2015
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0486-z

Other articles of this Issue 1/2015

Cancer Causes & Control 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine